Testing effectiveness (Phase 2)Study completedNCT01585428
What this trial is testing
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
Who this might be right for
Cervical CancerOropharyngeal CancerVaginal Cancer+2 more
National Cancer Institute (NCI) 29